Solutions

RNAi

Next generation gene control solutions for enhanced RNAi product development

RNAi

Next generation RNAi therapeutics

Laverock's gene silencing platform provides programmable, stable, tunable and specific gene silencing activity, unlocking targets that may be non-tractable with current approaches. Our technology is inherently stable, avoiding bolus affects and epigenetic silencing, and has unparallel tunability – dialing gene expression to the precise level required for disease control. Our approach also minimises off-target effects by recoding miRNAs specifically expressed in the target cell type. ​

Our RNA design and screening capabilities can also support the development of conventional RNAi approaches – helping you design and identify the optimal silencing RNA using our high-throughput platform.

siRNA

  • Stable
  • Fully tunable gene silencing
  • Cell type specific miRNA selection
  • Multiplex capability
  • Allele / mutation specific gene targeting

shRNA

  • Stable
  • Fully tunable gene silencing
  • Cell type specific miRNA selection
  • Multiplex capability
  • Allele / mutation specific gene targeting